Discontinued — last reported Q4 '24
BeiGene — Total revenues
Amgen BeiGene — Total revenues remained flat by 0.0% to $64.75M in Q4 2024 compared to the prior quarter. Year-over-year, this metric grew by 107.2%, from $31.25M to $64.75M. Over 2 years (FY 2022 to FY 2024), BeiGene — Total revenues shows an upward trend with a 101.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful product adoption, market penetration, or favorable contract terms within the partnership, while a decrease may signal market saturation, competitive pressure, or changes in the collaboration agreement.
Detailed definition
This metric represents the total gross revenue generated from the collaboration and commercialization agreement with Bei...
Peer comparison
Similar to other strategic alliance revenue or co-promotion income reported by large-cap biopharmaceutical companies, this metric is often compared against total segment revenue or total corporate revenue to assess the contribution of external partnerships.
amgn_segment_beigene_total_revenuesHistorical Data
| FY'22 | FY'23 | FY'24 | |
|---|---|---|---|
| Value | $64.00M | $125.00M | $259.00M |
| YoY Change | — | +95.3% | +107.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Amgen's beigene — total revenues?
- Amgen (AMGN) reported beigene — total revenues of $64.75M in Q4 2024.
- How has Amgen's beigene — total revenues changed year-over-year?
- Amgen's beigene — total revenues increased by 107.2% year-over-year, from $31.25M to $64.75M.
- What is the long-term trend for Amgen's beigene — total revenues?
- Over 2 years (2022 to 2024), Amgen's beigene — total revenues has grown at a 101.2% compound annual growth rate (CAGR), from $64.00M to $259.00M.
- What does beigene — total revenues mean?
- Total revenue earned from the company's strategic partnership and product collaboration with BeiGene.